Dr Glenn W Mclaughlin, MD | |
305 W Pennsylvania Ave, Anaconda, MT 59711-1900 | |
(406) 563-8686 | |
(406) 563-8691 |
Full Name | Dr Glenn W Mclaughlin |
---|---|
Gender | Male |
Speciality | Obstetrics & Gynecology |
Location | 305 W Pennsylvania Ave, Anaconda, Montana |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1447289970 | NPI | - | NPPES |
1447289970 | Other | MT | NPI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | 35-045226 (Ohio) | Primary |
Entity Name | Community Hospital Of Anaconda |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1538597703 PECOS PAC ID: 8123938974 Enrollment ID: O20031119000745 |
News Archive
In interviews Tuesday, Louisiana Gov. Bobby Jindal said Republicans need to lay out their own plans for health reform, rather than just rejecting Democratic proposals..
The researchers from Brigham and Women's Hospital this week have come up with a new study which shows that reducing the inflammation among patients who have already had a heart attack before could prevent the risk of getting more cardiovascular events. The study is published in the latest issue of the New England Journal of Medicine.
K-V Pharmaceutical Company today announced that it has entered into a definitive agreement with a group of institutional investors to raise approximately $32 million of gross proceeds from a private placement of 9,950,000 shares of its Class A Common Stock at $3.25 per share.
New research announced at the International Liver CongressTM 2014 today provides new hope for the notoriously difficult-to-treat population of liver transplant patients with recurring hepatitis C (HCV).
› Verified 7 days ago
Entity Name | Barrett Hospital Development Corporation |
---|---|
Entity Type | Part B Supplier - Hospital Department(s) |
Entity Identifiers | NPI Number: 1396286480 PECOS PAC ID: 4082904487 Enrollment ID: O20170223001015 |
News Archive
In interviews Tuesday, Louisiana Gov. Bobby Jindal said Republicans need to lay out their own plans for health reform, rather than just rejecting Democratic proposals..
The researchers from Brigham and Women's Hospital this week have come up with a new study which shows that reducing the inflammation among patients who have already had a heart attack before could prevent the risk of getting more cardiovascular events. The study is published in the latest issue of the New England Journal of Medicine.
K-V Pharmaceutical Company today announced that it has entered into a definitive agreement with a group of institutional investors to raise approximately $32 million of gross proceeds from a private placement of 9,950,000 shares of its Class A Common Stock at $3.25 per share.
New research announced at the International Liver CongressTM 2014 today provides new hope for the notoriously difficult-to-treat population of liver transplant patients with recurring hepatitis C (HCV).
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Glenn W Mclaughlin, MD 305 W Pennsylvania Ave, Anaconda, MT 59711-1900 Ph: (406) 563-8686 | Dr Glenn W Mclaughlin, MD 305 W Pennsylvania Ave, Anaconda, MT 59711-1900 Ph: (406) 563-8686 |
News Archive
In interviews Tuesday, Louisiana Gov. Bobby Jindal said Republicans need to lay out their own plans for health reform, rather than just rejecting Democratic proposals..
The researchers from Brigham and Women's Hospital this week have come up with a new study which shows that reducing the inflammation among patients who have already had a heart attack before could prevent the risk of getting more cardiovascular events. The study is published in the latest issue of the New England Journal of Medicine.
K-V Pharmaceutical Company today announced that it has entered into a definitive agreement with a group of institutional investors to raise approximately $32 million of gross proceeds from a private placement of 9,950,000 shares of its Class A Common Stock at $3.25 per share.
New research announced at the International Liver CongressTM 2014 today provides new hope for the notoriously difficult-to-treat population of liver transplant patients with recurring hepatitis C (HCV).
› Verified 7 days ago
Dr. Jennifer D Austin, D.O. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 305 W Pennsylvania Ave, Anaconda, MT 59711 Phone: 406-563-8686 Fax: 406-563-8691 |